Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-05-15
1999-08-03
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514417, 514570, 544220, 548473, 562459, 562463, A61K 3153, C07D25100, C07D20948, C07C 6532
Patent
active
059325771
ABSTRACT:
The present invention provides pharmaceutical compositions and methods for treating certain conditions associated with matrix metalloproteases comprising administering an amount of a compound or composition of the invention which is effective to inhibit the activity of at least one matrix metalloprotease, resulting in achievement of the desired effect. The compounds of the present invention are either of the generalized formula: ##STR1## wherein y is 0, 2, or, 3, r is 0-6, Z is (CH.sub.2).sub.7 or (CH.sub.2).sub.e --C.sub.6 H.sub.4 --(CH.sub.2).sub.f, wherein e is 0-1 and f is 0-5, and R.sup.15 is --H, --Cl, --OMe or ##STR2## wherein n is 0-4, R.sup.17 is C.sub.2 H.sub.5, alkyl, benzyl, and R.sup.16 is ##STR3## wherein t is 0-2, x is 0-4, and R.sup.4 is one of the following: halide, alkyl of 1-6 carbons, OR, NR.sub.2, NO.sub.2 (R=H or alkyl of 1-6 carbons).
REFERENCES:
Sahoo, et al., Inhibition of Matrix Metalloproteinases by N-Carboxyalkyl Dipeptides: Enhanced Potency and Selectivity with Substituted P.sub.1 ' Homophenylanines, Biorganic & Medicinal Chemistry Letters, 5(20), 2441-2446 (1995).
Child, et al., Fenbufen, a New Anti-Inflammatory Analgesic: Synthesis and Structure-Activity Relationships of Analogs, Journal of Pharmaceutical Sciences, 66(4), 466-476 (1977).
Brittelli David R.
Chen Jinshan
Dixon Brian R.
VanZandt Michael C.
Bayer Corporation
Geist Gary
Keys Rosalynd
LandOfFree
Substituted oxobutyric acids as matrix metalloprotease inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted oxobutyric acids as matrix metalloprotease inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted oxobutyric acids as matrix metalloprotease inhibitor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849679